Compounded Tirzepatide No Longer Available Nationwide
Breaking News: The FDA has removed tirzepatide from the national drug shortage list, impacting its availability nationwide. Tirzepatide, the active ingredient in medications such as Mounjaro® and Zepbound®, can no longer be compounded per federal regulations.
What This Means for Our Patients
At Medical Health Solutions, we understand that this change may be concerning, especially for those relying on compounded tirzepatide as a cost-effective weight loss option. We are committed to providing you with alternative treatments and ensuring a smooth transition.
At Medical Health Solutions, we understand that this change may be concerning, especially for those relying on compounded tirzepatide as a cost-effective weight loss option. We are committed to providing you with alternative treatments and ensuring a smooth transition.
Transition from Compounded Tirzepatide to Semaglutide
We are dedicated to supporting patients through this change by offering compounded semaglutide, an effective alternative for weight loss that many patients have found beneficial.
Why the Change?
With tirzepatide no longer on the shortage list, compounded versions are now prohibited by the FDA. Our focus remains on providing patients with available, effective treatments like semaglutide.
Understanding the Difference Between Compounded Semaglutide and Compounded Tirzepatide
Both semaglutide and tirzepatide help with weight loss by controlling hunger and affecting how the body processes sugar. Here’s a comparison of these options.
Semaglutide
Mechanism
Mimics the GLP-1 hormone, signaling fullness and slowing digestion to reduce appetite.
Name Brand Options
Ozempic® or Wegovy®
Dosage
Weekly injections beginning at 0.25 mg, increasing every 4 weeks up to 2.4 mg.
Side Effects
Mild effects such as nausea, constipation, and diarrhea, which typically lessen over time
Expected Results
Weight loss potential of 16-18% of body weight
Tirzepatide (Now Restricted)
Mechanism
Targets GLP-1 and GIP hormones for enhanced fullness and controlled appetite
Name Brand Options
Mounjaro® or Zepbound®
Dosage
Weekly injections starting at 2.5 mg, increasing every 4 weeks to a maximum of 12 mg.
Side Effects
Mild effects like nausea, constipation, and diarrhea, usually temporary
Expected Results
Weight loss potential of 18-22% of body weight per year
Next Steps: Considering Semaglutide as an Alternative
Semaglutide remains an effective option in weight management, with a track record of success for many patients. If you are considering switching to semaglutide, our team is available to answer questions and discuss your options.
Compounded semaglutide offers a cost-effective GLP-1 option to continue supporting your weight loss goals.
Patient Support and Affordability
Affordability
Compounded semaglutide offers a cost-effective GLP-1 option to continue supporting your weight loss goals.
No Treatment Delays
Our team is working diligently to ensure that treatment continues without delays. For any questions about transitioning from compounded tirzepatide, please reach out to discuss your options.
We understand that medication changes can be challenging, but compounded semaglutide provides similar benefits and has been a trusted weight loss solution for many patients.
Ongoing Support
We are committed to making this transition as smooth as possible. Our care team is here to address any questions, provide guidance, and support you at every step of your journey.
Medical Health Solutions in Lone Tree, Colorado offers medical weight loss. The plan helps people lose weight without hunger, dieting or exercise.
